































































Brain endothelial tricellular junctions as novel sites for T cell
diapedesis across the blood–brain barrier
Mariana Castro Dias1, Adolfo Odriozola Quesada2, Sasha Soldati1, Fabio Bösch1, Isabelle Gruber1,
Tobias Hildbrand1, Derya Sönmez1, Tejas Khire3, Guillaume Witz4,5, James L. McGrath3, Jörg Piontek6,
Masuo Kondoh7, Urban Deutsch1, Benoît Zuber2 and Britta Engelhardt1,*
ABSTRACT
The migration of activated T cells across the blood–brain barrier
(BBB) is a critical step in central nervous system (CNS) immune
surveillance and inflammation. Whereas T cell diapedesis across the
intact BBB seems to occur preferentially through the BBB cellular
junctions, impaired BBB integrity during neuroinflammation is
accompanied by increased transcellular T cell diapedesis. The
underlying mechanisms directing T cells to paracellular versus
transcellular sites of diapedesis across the BBB remain to be
explored. By combining in vitro live-cell imaging of T cell migration
across primary mouse brain microvascular endothelial cells
(pMBMECs) under physiological flow with serial block-face scanning
electron microscopy (SBF-SEM), we have identified BBB tricellular
junctions as novel sites for T cell diapedesis across the BBB.
Downregulated expression of tricellular junctional proteins or protein-
based targeting of their interactions in pMBMECmonolayers correlated
with enhanced transcellular T cell diapedesis, and abluminal presence
of chemokines increased T cell diapedesis through tricellular junctions.
Our observations assign an entirely novel role to BBB tricellular
junctions in regulating T cell entry into the CNS.
This article has an associated First Person interviewwith the first author
of the paper.
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INTRODUCTION
Maintenance of central nervous system (CNS) homeostasis is a
prerequisite for proper neuronal function and is ensured by the
endothelial blood–brain barrier (BBB), which allows for a
separation between blood and the neural tissue. Continuous and
complex tight junctions between adjacent BBB endothelial cells
combined with lack of fenestrations and low pinocytotic activity
prohibit uncontrolled paracellular and transcellular diffusion of
water-soluble molecules across the BBB (Daneman, 2012;
Engelhardt and Sorokin, 2009). Claudin-5, occludin and
junctional adhesion molecules (JAMs) compose the BBB tight
junctions that represent the core structure that actively seals the
paravascular space between CNS microvascular endothelial cells in
the brain (Castro Dias et al., 2019b). At the same time, transport of
necessary nutrients into the CNS and export of potentially toxic
metabolites is ensured by a multitude of specific transporters and
enzymes expressed by BBB endothelial cells (Sweeney et al., 2019).
The BBB also strictly controls immune cell trafficking into the
CNS. In homeostatic conditions, passage of immune cells across the
BBB into perivascular or subarachnoid spaces is limited to activated
CD4+ and CD8+ T cells, allowing for CNS immune surveillance
(Marchetti and Engelhardt, 2020). However, in neuroinflammation
such as in multiple sclerosis (MS) or its animal model,
experimental autoimmune encephalomyelitis (EAE), increased
numbers of immune cells breach the BBB and infiltrate the CNS
parenchyma leading to clinical disease (Sallusto et al., 2012;
Engelhardt et al., 2017).
Accounting for the unique tightness of the BBB, multi-step T cell
migration across the BBB is characterized by unique adaptations
(Marchetti and Engelhardt, 2020). Firm arrest of T cells to the BBB
endothelium is mediated by the T-cell integrins LFA-1 (αLβ2
integrin) and VLA-4 (α4β1 integrin) engaging their endothelial
ligands, ICAM-1 and VCAM-1, respectively. Following their arrest,
T cells polarize and crawl over extended distances on the BBB
endothelium against the direction of blood flow in an ICAM-1- and
ICAM-2-dependent manner searching for rare sites permissive for
diapedesis (Bartholomäus et al., 2009; Steiner et al., 2010). At
the ultrastructual level, T cell crawling can be observed to require
the continuous extension and retraction of T cell protrusions into the
BBB endothelium (Abadier et al., 2015). T cell diapedesis across
the BBB finally occurs either paracellularly, through the endothelial
cell junctions, or transcellularly, through the endothelial cell body,
via a pore-like structure (Engelhardt and Wolburg, 2004). In
contrast to peripheral vascular beds, where leukocyte diapedesis
occurs mainly through the endothelial cell junctions (Muller, 2015),
the inflamed BBB rather favors transcellular T cell diapedesis,
possibly by a caveolin-1-dependent mechanism (Wolburg et al.,
2005; Lutz et al., 2017). We have previously shown that under low
inflammatory conditions, low brain endothelial cell surface
expression of ICAM-1 directs T cells to paracellular sites of
diapedesis, whereas high expression levels of endothelial ICAM-1
during exacerbated inflammation prohibit T-cell crawling on the
BBB and promote a shift towards transcellular diapedesis (Abadier
et al., 2015). As neuroinflammation is accompanied by the loss of
BBB tight junction integrity, these findings show that the route of
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T cell diapedesis across the BBB is regulated independently of
mechanisms regulating tight junction integrity. Similarly, absence
of PECAM-1 from the BBB cell–cell contacts, which leads to
impaired junctional integrity, results in increased transcellular T cell
diapedesis across the BBB (Wimmer et al., 2019). Taken together,
these observations underscore that the BBB endothelium plays an
active role in directing T cells to paracellular or transcellular sites of
diapedesis; however, the underlying mechanisms remain incompletely
understood.
In this study, we aimed to identify subcellular structures
accompanying transcellular versus paracellular T cell diapedesis
across the BBB under physiological flow at the ultrastructural level.
Combining microfluidics using primary mouse brain microvascular
endothelial cells (pMBMECs) with live-cell imaging and serial
block-face scanning electron microscopy (SBF-SEM) allowed us to
conduct a three-dimensional (3D) ultrastructural analysis of T cell
diapedesis across the BBB under low and high inflammatory
conditions. With this experimental approach, we made the
surprising observation that under low inflammatory conditions T
cell diapedesis across pMBMECs preferentially occurs through
tricellular junctions. High inflammatory conditions with increased
transcellular T cell diapedesis were associated with downregulation
of tricellulin (also known as MARVELD2) and lipolysis-stimulated
lipoprotein receptor (also known as angulin-1, referred to hereafter
as LSR/angulin-1), the molecules forming tricellular junctions of
epithelial layers and the BBB. Protein-based targeting of LSR/
angulin-1 and claudin-5 in pMBMECs under physiological flow
in vitro led to reduced paracellular and enhanced transcellular T cell
diapedesis, whereas abluminal deposition of inflammatory
chemokines directed T cell diapedesis to tricellular junctions.
Taken together, the combination of in vitro live-cell imaging, 3D
ultrastructural analysis and functional assays allowed us to identify
BBB tricellular junctions as relevant sites for T cell diapedesis in
this vascular bed.
RESULTS
Phenotype and barrier characteristics of pMBMECs in non-
stimulated and inflammatory conditions
We made use of our well characterized in vitro model of the mouse
BBB established from pMBMECs (Coisne et al., 2005). pMBMECs
were either non-stimulated or stimulated with 0.05 ng/ml of IL-1β
(IL-1βlo) or 20 ng/ml of IL-1β (IL-1βhi), previously shown to induce
low and high cell surface levels of ICAM-1 on the BBB
endothelium, favoring paracellular and transcellular diapedesis,
respectively (Abadier et al., 2015). First, we confirmed that IL-1βlo
and IL-1βhi pMBMECs showed low and high cell surface levels,
respectively, of ICAM-1 and VCAM-1, with a characteristic
heterogenous expression pattern between the individual brain
endothelial cells (Fig. 1A,B), as previously described (Abadier
et al., 2015). Although we found a slight increase in non-junctional
immunostaining for the tight junction protein occludin and
formation of F-actin stress fibers in IL-1βlo- and IL-1βhi-
stimulated pMBMECs versus non-stimulated pMBMECs
(Fig. 1A), the junctional localizations of the tight junction protein
claudin-5, the adherens junction protein VE-cadherin (also known
as CDH5) and the junctional scaffolding protein ZO-1 (also known
as TJP1) were found to be unaltered in both non-stimulated and
IL-1β-stimulated pMBMECs (Fig. 1A). This suggests that the
overall junctional architecture of pMBMECs is still intact under
these inflammatory conditions. Quantification of claudin-5 and
occludin protein levels confirmed that there were no significant
differences between non-stimulated and IL-1β-stimulated
pMBMECs (Fig. 1B), although we did notice a trend towards a
decrease in claudin-5 protein levels in IL-1βhi-stimulated
pMBMECs (Fig. 1B). Considering that pro-inflammatory
cytokines can induce impaired barrier characteristics of the BBB,
we investigated the permeability of pMBMECs to Lucifer Yellow
(0.4 kDa) and 3 kDa dextran (Fig. 1C). In accordance with our
previous observations (Abadier et al., 2015), we found a visible,
although not quite significant, increase in permeability for Lucifer
Yellow and for 3 kDa dextran across IL-1βhi-stimulated pMBMECs
compared to non-stimulated and IL-1βlo-stimulated pMBMECs
(Fig. 1C). Thus, IL-1βlo- and IL-1βhi-stimulated pMBMECs
showed gradually increased expression of VCAM-1 and ICAM-1
compared to expression in non-stimulated pMBMECs. This was
accompanied by a trend towards impaired junctional integrity and
higher permeability in IL-1βhi versus IL-1βlo and non-stimulated
pMBMEC monolayers.
The BBB directs T cell diapedesis to tricellular junctions
To study subcellular structures involved in transcellular versus
paracellular diapedesis of CD4+ effector-memory T (TEM) cells
across the BBB, we combined in vitro live-cell imaging with
microfluidics and SBF-SEM technology. Activated CD4+ TEM cells
were perfused over IL-1βlo- or IL-1βhi-stimulated pMBMECs in a
custom-made flow chamber (Coisne et al., 2013) with physiological
shear forces, and the interaction was fixed under flow after 13 min, a
time point where most of the T cells are in the process of diapedesis
across the pMBMECs. Retaining the precise orientation of the
direction of flow, the samples were processed for SBF-SEM.
Samples were cut and images were collected in 60 nm steps in the
perpendicular plane against the direction of flow previously applied
in the flow chamber (Fig. 2A). A total of 2000 images of CD4+ TEM
cells interacting with either IL-1βlo- or IL-1βhi-stimulated
pMBMECs were taken per assay (Fig. 2A). We first observed that
organelles in CD4+ TEM cells in close contact with the IL-1β
lo or IL-
1βhi pMBMECs and prior to the initiation of diapedesis were
distributed throughout the entire T cell body (Fig. 2B). In contrast,
as soon as CD4+ TEM cells started diapedesis, as defined by
insertion of at least part of the nucleus across the pMBMEC
monolayer, most T cell organelles, especially mitochondria,
accumulated towards the rear of the T cell and remained in this
polarized localization during the diapedesis process (Fig. 2C,D).
Furthermore, we observed that the individual CD4+ TEM cells
send numerous protrusions into and across the pMBMECs prior
to insertion of the T cell nucleus across the pMBMECmonolayer,
the latter being defined as the definite T cell diapedesis site
(Barzilai et al., 2017) (Fig. 2D). In both, IL-1βlo- and IL-1βhi-
stimulated pMBMECs, we observed that CD4+ TEM cells inserted
a comparable number of protrusions across the pMBMEC
monolayers, with a significantly higher number of protrusions
found through the endothelial cell body compared to through the
endothelial cell junctions (Fig. 2E,F). The formation of T cell
protrusions is thus independent of the inflammatory state of the
BBB and rather seems to be a T cell-mediated process that allows
the T cell to search for sites permissive for diapedesis.
To visualize the pathway of diapedesis, we turned our image
blocks through 90° in order to look at a transversal plane precisely at
the level where CD4+ TEM cells were in contact with pMBMECs
(Fig. 3A). To identify cells in diapedesis, we analyzed all T cells that
had at least part of their nucleus inserted through the pMBMEC
monolayer, as detected in the frontal sections. Using the transversal
sections, we categorized CD4+ TEM cell diapedesis into paracellular
or transcellular routes by determining whether or not the T cell
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Fig. 1. See next page for legend.
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disturbed the visible ultrastructure of the junctions. In agreement
with our previous work (Abadier et al., 2015), we observed that in
the presence of IL-1βlo, most of the cells preferentially extravasated
through the pMBMEC junctions, whereas in IL-1βhi conditions
more T cells were found to undergo transcellular diapedesis
(Fig. 3B). In this context, we asked whether there were differences
between the morphology of the nuclei of T cells that were
undergoing transcellular compared to those of T cells undergoing
paracellular diapedesis. 3D segmentation of these nuclei allowed us
to observe that irrespective of the cellular diapedesis pathway, the T
cell nuclei assumed very dynamic shapes, characterized by the
presence of nuclear lobes (Fig. S1).
To our surprise, we noticed that paracellular diapedesis of CD4+
TEM cells was not restricted to bicellular endothelial junctions, but
rather often occurred at tricellular contacts, a junctional point where
three adjacent endothelial cells meet (Fig. 3C). Differentiating
paracellular CD4+ TEM cell diapedesis into bicellular versus
tricellular diapedesis showed that 60% of CD4+ TEM cells crossed
the pMBMEC monolayer at tricellular contacts rather than at
bicellular junctions under low inflammatory conditions (Fig. 3C).
To verify that T cell diapedesis through tricellular junctions is not
a random event, we established a null model in which the
probability of transcellular versus paracellular diapedesis through
bicellular or tricellular junctions was directly proportional to the
frequency of their occurrence in a pMBMEC monolayer. By
segmenting the cell boundaries of the pMBMEC monolayers and
assigning an increasing radius to the cellular junctions, wewere able
to calculate the frequency of transcellular, bicellular and tricellular
junctional diapedesis events if they were to occur in a random
fashion in direct correlation to the number of pixels belonging to
each category (Fig. S2). Although this model did not include an
estimation of the true thickness of pMBMEC junctions, it allowed
us to determine that, even under the assumption of a radius of 6 µm
for cellular junctions, the frequency of tricellular events would not
reach a fraction of 25% (Fig. S2D). This confirmed that BBB
tricellular junctions serve as non-random sites for CD4+ TEM cell
diapedesis across the BBB, especially under low inflammatory
conditions.
Finally, we also determined whether transcellular versus
paracellular CD4+ TEM cell diapedesis required differentially
sized pores within one endothelial cell or between two endothelial
cells, respectively. To this end, we measured the diameter of the
endothelial pores formed during the CD4+ TEM cell diapedesis
events. Independently of the inflammatory stimulus and the cellular
pathway of T diapedesis, the diameter of the pore formed within one
pMBMEC or between two or three pMBMECs was close to 5 µm
(Fig. 3D), suggesting that this pore size is a minimal requirement for
T cell diapedesis across the BBB irrespective of the absence or
presence of inflammation.
Tricellulin and LSR/angulin-1 are expressed in pMBMECs and
are downregulated under inflammatory conditions
Based on our observations using SBF-SEM, it seemed that under
low inflammatory conditions CD4+ TEM cells preferentially crossed
the pMBMEC monolayers via tricellular junctions. We decided to
confirm this observation by performing in vitro live-cell imaging of
activated CD4+ TEM cells interacting with IL-1β
lo- or IL-1βhi-
stimulated pMBMECs isolated from VE-cadherin–GFP C57BL/6J
mice under physiological flow conditions. Identification of
pMBMEC junctions based on their GFP signal allowed us to
confirm that under low inflammatory conditions CD4+ TEM cells
cross the pMBMEC monolayer preferentially via tricellular
junctions (Fig. 4 and Fig. 8A). In an attempt to understand the
signals directing CD4+ TEM cells to tricellular contacts, we next
wanted to confirm which proteins are specifically localized at
tricellular contacts in the pMBMEC monolayers. Tricellulin and
LSR/angulin-1 are specifically expressed in brain endothelial cells
and localize to tricellular BBB endothelial junctions (Sohet et al.,
2015; Iwamoto et al., 2014). Thus, we first asked whether tricellulin
and the angulin proteins are expressed in pMBMECs, whether they
are localized to tricellular contacts, and whether their expression is
affected by inflammation. RNAseq transcriptome analysis (Fig. 5A;
Castro Dias et al., 2019a) and RT-qPCR (Fig. 5B) confirmed
mRNA expression of tricellulin, LSR/angulin-1 and angulin-3 (also
known as ILDR2), but not angulin-2 (also known as ILDR1), in
pMBMECs. To confirm tricellular localization of tricellulin and
LSR/angulin-1, we performed immunostaining of tricellulin and
LSR/angulin-1 on pMBMEC monolayers and on monolayers of the
epithelial EpH4 cell line, as a positive control (Masuda et al., 2011;
Ikenouchi et al., 2005). Although we readily detected tricellular
localization of both proteins in epithelial monolayers, we could not
observe any positive immunostaining of pMBMECs using either
polyclonal or monoclonal mouse anti-tricellulin and anti-LSR/
angulin-1 antibodies (Fig. S3 and data not shown). Protein
expression of tricellulin and LSR/angulin-1 in pMBMECs could,
however, be confirmed by western blotting (Fig. 5C,E).
Next, we quantified the expression levels of tricellulin and LSR/
angulin-1 proteins in pMBMECs in the context of inflammation. As
a positive control we used epithelial cell lysates from EpH4 cells,
and as a negative control we used lysates from L cells, a fibroblast
cell line (Furuse et al., 1999).We found that IL-1βhi- but not IL-1βlo-
stimulated pMBMECs showed downregulated expression of
tricellulin (Fig. 5C). With respect to LSR/angulin-1, three
different splice variants are described in the mouse genome:
isoform 1, isoform 2 and isoform 3 (Higashi et al., 2013; Fig. 5D).
Isoform 1 is considered the canonical form and is translated to a full-
length protein (67 kDa band). Isoform 2 lacks part of the
immunoglobulin-like domain (64 kDa band), and isoform 3 does
not possess the transmembrane domain (58 kDa band) (Fig. 5D).
Their respective roles in forming or maintaining tricellular junctions
is still unknown. Using an antibody that detects the N-terminal part
shared by the three LSR/angulin-1 isoforms we could detect
expression of isoform 1 and 2, with band sizes between 64 and
67 kDa, as well as isoform 3 as a 58 kDa band in lysates from
pMBMECs (Fig. 5E), in accordance with previous observations by
others (Sohet et al., 2015). Under IL-1βhi but not under IL-1βlo
stimulation of pMBMECs, all LSR/angulin-1 isoforms showed a
trend towards a downregulation, with isoform 2 being significantly
Fig. 1. Phenotype and barrier characteristics of pMBMEC monolayers.
(A) Immunofluorescence staining of non-stimulated (NS), IL-1βlo- or IL-1βhi-
stimulated pMBMEC monolayers. Immunostaining for claudin-5 (red) or
occludin (red), F-actin staining (red) in VE-Cadherin–GFP+ (green) pMBMECs,
and immunostaining for ZO-1 (red) and either ICAM-1 or VCAM-1 (green) are
shown. Nuclei are stained with DAPI (blue). Data are representative of three
independent experiments. (B) Immunoblot analysis and quantification of
claudin-5, occludin and ICAM-1 in non-stimulated, IL-1βlo- or IL-1βhi-stimulated
pMBMECs is shown. β-actin is shown as a loading control used for
normalization during quantification. Bar graphs show mean±s.d. of four
independent experiments (AU, arbitrary units). *P<0.05; **P<0.01 (one-way
ANOVAwith a Tukey post hoc test). (C) Permeability of 0.45 kDa Lucifer Yellow
and 3 kDa dextran across unstimulated, IL-1βlo- or IL-1βhi-stimulated pMBMEC
monolayers is shown. Endothelial permeability coefficient (Pe) values were
calculated as previously described (Steiner et al., 2011). Bar graphs show
mean±s.d. of four independent experiments, with triplicates performed per
condition.
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Fig. 2. SBF-SEM of CD4+ TEM interacting with pMBMECs under physiological flow. (A) Scheme of the acquisition made using SBF-SEM (left) and
corresponding representative image (right) of this frontal plane (red frame). Image collection was performed precisely against the direction of the flow (arrows). In
the example chosen, three CD4+ TEM cells interacting with the endothelial monolayer are demonstrated. Scale bar: 1 µm. (B–D) Representative images of three
different CD4+ TEM cells interacting with the pMBMECmonolayer under flow. For each T cell, four SBF-SEM image sections are shown, depicting the interaction of
different frontal section planes of the same cell with the endothelium. Images are false colored to show endothelial cells in red, extracellular matrix in green, T cell
cytoplasm in light blue and T cell nuclei in bright blue. In B, four images of the same T cell in close contact with the pMBMEC monolayer are shown. In the first,
second and fourth images, no disruption of the pMBMEC monolayer by the T cell is visible. In the third image from the left, the orange arrow marks a T cell
protrusion through the pMBMEC monolayer. The organelles of the T cell are visibly concentrated around the nucleus. Yellow arrows point to two exemplary
mitochondria. In C, another T cell is sending a subendothelial protrusion across the pMBMEC monolayer, directly visible in sections three and four (highlighted
with a yellowasterisk). Yellow arrows point to exemplary mitochondria accumulating at the rear of the T cell. In D, a third T cell is undergoing a diapedesis process,
where part of the T cell nucleus is already seen underneath the endothelium. Yellow arrows highlight exemplary mitochondria concentrated at the rear of the
T cell. The imageswere acquired at an angle perpendicular to the physiological flow. Scale bars:1 µm. (E,F) Quantification of the number of protrusions each T cell
sent across the junctions or across the endothelial cell body of (E) IL-1βlo- or (F) IL-1βhi-stimulated pMBMECs. For both datasets, a total of ten T cells were
evaluated under IL-1βlo and IL-1βhi stimulation, from four independent samples. Analysis was done by evaluating the SBF-SEM dataset using 3dmod
software. Data are presented as mean±s.d. *P<0.05; ***P<0.01 (two-tailed, unpaired Student’s t-test).
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downregulated (Fig. 5E). Downregulated protein expression of
tricellulin and LSR/angulin-1 in IL-1βhi-stimulated pMBMECs
may thus lead to impaired stabilization of BBB tricellular and
bicellular junctions, as previously observed for epithelial cells
(Ikenouchi et al., 2005; Krug et al., 2009;Masuda et al., 2011; Sohet
et al., 2015).
Targeting LSR/angulin-1 reduces paracellular CD4+ TEM cell
diapedesis via bicellular rather than tricellular junctions
Downregulated expression of tricellulin and LSR/angulin-1 in
highly inflamed pMBMECs correlated with increased transcellular
T cell diapedesis. Because we have previously observed that altered
molecular composition of endothelial bicellular junctions shifts
CD4+ TEM cell diapedesis across the BBB to transcellular sites
(Wimmer et al., 2019), we next asked whether targeting tricellular
junctional proteins would favor transcellular T cell diapedesis
across pMBMECs. To this end we used angubindin-1, which
consists of amino acids 421–664 of iota-toxin Ib (also known as Ibp)
from Clostridium perfringens. Angubindin-1 binds to the
N-terminal part of LSR/angulin-1 as a function blocking probe
(Fig. 6A) and has previously been shown to remove LSR/angulin-1
from the tricellular tight junctions (Krug et al., 2017). As a
negative control, we used recombinant C2 protein, corresponding
to amino acids 592–721 of C2 toxin of Clostridium botulinum
(Krug et al., 2017).
We first investigated whether angubindin-1 would impact on the
barrier characteristics of pMBMECs. IL-1βlo- or IL-1βhi-stimulated
pMBMECs were incubated during stimulation with either no
protein, a control protein or with angubindin-1. Although
angubindin-1 has previously been found to increase the
permeability of epithelial layers (Krug et al., 2017), we did not
observe an angubindin-1-induced change in the endothelial
permeability to 0.45 kDa Lucifer Yellow or 3 kDa dextran when
compared that of the control cells (Fig. 6B). Moreover, we did not
see any angubindin-1-induced effects on expression and location of
claudin-5, ZO-1, ICAM-1, VCAM-1 and VE-cadherin (Figs S4, S5
and data not shown). As a next step, we investigated the effect of
angubindin-1 on the cellular pathway of T cell diapedesis across
pMBMECs. Following incubation with control peptide or
angubinding-1, we imaged the interaction of CD4+ TEM cells with
IL-1βlo- and IL-1βhi-stimulated VE-cadherin–GFP+ pMBMECs
under physiological flow (Fig. 4). The number of arrested CD4+
TEM cells on the pMBMEC monolayers was comparable between
the control protein- and angubindin-1-treated monolayers (Fig. 6C,
D). Surprisingly, when the pMBMECs were incubated with
angubindin-1, the number of arrested T cells on IL-1βhi-
stimulated pMBMECs was increased compared to the number of
arrested T cells on IL-1βlo-stimulated monolayers (Fig. 6C).
Analysing the cellular pathway of T cell diapedesis, we confirmed
our earlier observations that under IL-1βlo stimulation the majority
of T cells crossed the pMBMEC monolayer via the paracellular
pathway, whereas under IL-1βhi stimulation transcellular T cell
diapedesis was significantly increased (Fig. 6D and Fig. 8A).
Whereas incubation with the control protein did not influence the
cellular pathway of T cell diapedesis across pMBMEC monolayers
(Fig. 6D), preincubation of IL-1βlo-stimulated pMBMECs with
angubindin-1 surprisingly reduced the fraction of paracellular
CD4+ TEM cell diapedesis via bicellular rather than tricellular
junctions, when compared to the controls (Fig. 6D). At the same
time, treatment with angubindin-1 did not further increase
transcellular CD4+ TEM cell diapedesis across IL-1βhi-stimulated
pMBMECs (Fig. 6D). Furthermore, angubidin-1 did not affect the
diapedesis duration of T cells across the different diapedesis routes
under both IL-1β stimulation conditions (Fig. 6E). Analysis of the
T cell crawling distance that preceded diapedesis also
demonstrated no differences in the presence of angubindin-1
(data not shown). Taken together, these observations show that
targeting LSR/angulin-1 in brain endothelium favors transcellular
T cell diapedesis across the endothelium without affecting the
endothelial barrier integrity.
Targeting endothelial claudin-5 decreases paracellular
CD4+TEM cell diapedesis across bicellular junctions
To test whether direct modulation of a component of the bicellular
junctions would also enhance transcellular T cell diapedesis events,
we targeted claudin-5, a bicellular junctional protein that is highly
expressed in BBB tight junctions, again using specific recombinant
protein inhibitors. The non-toxic C-terminal domain of Clostridium
perfringens enterotoxin (cCPE) binds to the extracellular segments 1
and 2 (ECS1 and ECS2) of a subset of claudins (Fujita et al., 2000;
Veshnyakova et al., 2012; Saitoh et al., 2015) (Fig. 7A). Structure-
based mutagenesis has previously been used to generate cCPE
variants with altered claudin subtype specificity. These have been
used as tight junction modulators that can reversibly open the BBB
allowing drug delivery into the CNS (Veshnyakova et al., 2012;
Protze et al., 2015; Neuhaus et al., 2018). In the present study, we used
two cCPE variants that bind to claudin-5: cCPE Y306W/S313H
(referred to hereafter as Cldn1,-3,-4,-5 modulator), which binds
to claudin-5 but also to claudin-1, claudin-3 and claudin-4; and
cCPE N218Q/Y306W/S313H (referred to hereafter as Cldn5
modulator), which preferentially binds to claudin-5 (Neuhaus
et al., 2018). Although claudin-1, -3 and -4 are not expressed in
pMBMECs (Castro Dias et al., 2019a), we still opted to use both
claudin-5-binding cCPE variants for comparison. As a negative
control, we used cCPE Y306A/L315A (referred to hereafter as
control protein), which does not recognize any claudin.
We first investigated the permeability of Lucifer Yellow and
3 kDa dextran across IL-1βlo- and IL-1βhi- stimulated pMBMECs, in
the presence and absence of control protein, Cldn1, -3, -4, -5
modulator or Cldn5 modulator. We did not observe any effect of the
recombinant proteins on permeability of Lucifer Yellow or 3 kDa
dextran across the pMBMECs (Fig. 7B). In accordance with
previous observations (Neuhaus et al., 2018), the cCPE variants did
not affect the bicellular localization of claudin-5 (Fig. 7C), nor did
they affect the expression of other junctional and adhesion
molecules, such as ZO-1, ICAM-1, VCAM-1 and VE-cadherin
(Fig. S6 and data not shown). To investigate whether the
recombinant proteins would affect the cellular pathway of CD4+
TEM cell diapedesis across pMBMEC monolayers, we isolated
pMBMECs from VE-cadherin–GFP mice and investigated CD4+
TEM cell interaction with IL-1β
lo-or IL-1βhi-stimulated pMBMEC
monolayers under physiological flow by live-cell imaging (Fig. 4).
The number of arrested CD4+ TEM cells and percentage of
diapedesis events on pMBMECs was not affected by recombinant
protein pulsing (Fig. 7D,E). We observed the expected ratios of T
cell diapedesis pathways with no protein pulsing and in the presence
of the control protein, with the majority of CD4+ TEM cells
preferentially migrating paracellularly under IL-1βlo stimulation,
whereas with IL-1βhi stimulation more CD4+ TEM cells migrated
transcellularly (Fig. 7E). Incubation of IL-1βlo-stimulated
pMBMECs with the Cldn5 modulator led to a significant
decrease of paracellular CD4+ TEM cell diapedesis across bicellular
junctions, while diapedesis across tricellular junctions was not
affected (Fig. 7E). Rather, we observed an increase in transcellular
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CD4+ TEM cell diapedesis events (Fig. 7E). Incubation of IL-1β
lo-
stimulated pMBMECs with the Cldn1, -3, -4, -5 modulator showed
similar, however, not quite significant effects compared to those of
the Cldn5 modulator (Fig. 7E). Transcellular T cell diapedesis
across IL-1βhi-stimulated pMBMEC monolayers was not further
increased by treatment with the Cldn5 modulator (Fig. 7E).
Finally, we measured the duration of the diapedesis process while
targeting claudin-5, to assess whether this allows for a faster
Fig. 3. CD4+ TEM cells extravasate across tricellular junctions of the pMBMECs. (A) Scheme of the acquisition made using SBF-SEM (left) and
correspondent representative images (right) of this transversal plane (blue frame). Turning the acquired image stack by 90° allowed us to visualize the precise
transversal plane of the interaction between the T cell and the pMBMEC monolayer. The images highlight an example of a transcellular diapedesis (left), an
example of a paracellular diapedesis via a bicellular junction (middle) and an example of paracellular diapedesis via a tricellular junction (right). The images in the
top row are false colored to show the different endothelial cells in red colors, the T cell cytoplasm in light blue, the T cell nucleus in bright blue and the junctions in
yellow. EC, one individual endothelial cell; T, T cell. Original images are shown in the lower row. Scale bar: 1 μm. (B,C) Quantification of the T cell diapedesis
pathways observed with SBF-SEM, using 3dmod software. Bar graphs show quantification of either (B) transcellular (black) and paracellular (gray) diapedesis, or
(C) transcellular (red), and paracellular diapedesis across bicellular (blue) and tricellular (gray) junctions, across IL-1βlo- or IL-1βhi-stimulated pMBMECs. For both
datasets, we identified a total of 86CD4+ TEM cells interacting with IL-1βlo-stimulated pMBMECsand 92CD4+ TEM cells interactingwith IL-1βhi-stimulated pMBMECs.
Of those, a total of 26 and 37 cells were performing diapedesis, respectively, and the pathway of diapedesis was evaluated under IL-1βlo and IL-1βhi conditions from
four independent samples. Datawere normalized to 100%. (D) Measurement of the endothelial pore diameter generated by CD4+ TEM diapedesis through IL-1βlo- or
IL-1βhi-stimulated pMBMECs, during transcellular diapedesis or paracellular diapedesis across bicellular or tricellular junctions. A total of 26 and 37 T cells were
evaluated under IL-1βlo and IL-1βhi stimulation, respectively, from four independent samples. Analysis was performed by evaluating the SBF-SEM dataset with
3dmod software. Data are presented as mean±s.d. No statistical differences were found with a one-way ANOVA with a Tukey post hoc test.
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Fig. 4. See next page for legend.
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paracellular diapedesis. As before, the crawling distance that
preceded the diapedesis event and the diapedesis duration across
the different diapedesis routes did not differ between the control
groups and the conditions targeting claudin-5, under both IL-1β-
stimulation conditions (Fig. 7F and data not shown). Taken
together, targeting claudin-5 – the main constituent of pMBMEC
bicellular tight junctions – under low inflammatory conditions
reduced paracellular CD4+ TEM cell diapedesis across pMBMECs
and increased transcellular diapedesis, with no visible impact on
barrier integrity or diapedesis duration.
Abluminal chemokines increase CD4+ T helper 1 cell
diapedesis across tricellular junctions
Our analysis of the limited number of T cell diapedesis events across
pMBMECs at the ultrastructural level suggested that T cell
diapedesis via tricellular junctions preferentially occurs under low
inflammatory conditions (Fig. 3C). However, when comparing the
cellular pathway of the several hundred T cell diapedesis events
across IL-1βlo- and IL-1βhi-stimulated VE-cadherin–GFP+
pMBMECs in the absence of peptide treatments (Figs 6, 7 and
8A), we found that ∼40% of T cells crossed the pMBMEC
monolayers via tricellular junctions irrespective of the inflammatory
conditions. In accordance with our previous observations (Abadier
et al., 2015), transcellular T cell diapedesis across IL-1βhi-
stimulated pMBMECs was significantly increased, while
paracellular T cell diapedesis across bicellular junctions was
significantly reduced, when compared to that across IL-1βlo-
stimulated pMBMECs (Fig. 8A).
To further explore the role of tricellular junctions in mediating T
cell diapedesis across the BBB, we asked whether chemotactic signals
delivered from the abluminal to the luminal side of pMBMECs via
tricellular junctions would direct T cell diapedesis across tricellular
junctions. The inflammatory chemokines CCL2 and CCL5mediate T
cell migration into the CNS during neuroinflammation (Mahad and
Ransohoff, 2003; Zang et al., 2000). We therefore in vitro polarized
CD4+ T helper 1 (Th1) cells and tested their chemotactic behavior
towards increasing concentrations of CCL2 and CCL5 across a
laminin-coated porous filter in a two-chamber assay over 2 h (Fig. S7).
Both CCL2 and CCL5 significantly enhanced T cell migration into
the lower chamber, reaching a peak at 100 ng/ml for both chemokines
(Fig. S7).
To test whether CCL2 and CCL5 could affect the cellular
pathway of T cell diapedesis across pMBMECs under physiological
flow, we cultured pMBMECs on nanoporous silicon nitride (NPN)
membranes in a two-chambered µSiM-CVB microfluidic device
(Fig. 8B; Mossu et al., 2019). CCL2 and CCL5 were added at a
concentration of 100 ng/ml to the bottom channel of the µSiM
device (i.e. at the basolateral side of IL-1βhi-stimulated pMBMECs)
2 h prior to in vitro live-cell imaging of T cell interaction with the
pMBMEC monolayer under physiological flow (Fig. 8B). The
presence of CCL2 and CCL5 neither affected the numbers of Th1
cells arresting on, nor the number of Th1 cells crossing, the
pMBMECmonolayers under physiological flow (Fig. 8C,D). At the
same time, addition of CCL2 and CCL5 to the bottom channel of the
µSiM microfluidic device significantly increased T cell diapedesis
via tricellular junctions and reduced transcellular T cell diapedesis
across IL-1βhi-stimulated pMBMECs (Fig. 8D). Taken together,
these observations suggest that BBB tricellular junctions may
provide a scaffold for chemokine gradients allowing the guidance of
T cell diapedesis to these unique junctional sites of the BBB.
DISCUSSION
In this study, we identify brain microvascular tricellular junctions as
important gateways for controlling T cell diapedesis across the BBB
under low and high inflammatory conditions. The molecular
composition and potential structure of tricellular junctions has
mainly been investigated in epithelial cells. There, the most apical
tight junction strands of the bicellular junctions meet at tricellular
junctions and continue basally, forming a vertical tube-like structure
referred to as the central sealing element (Staehelin et al., 1969).
While bicellular tight junctions are mainly composed of claudins,
occludin and JAMs (Tietz and Engelhardt, 2015), tricellular
junctions harbor tricellulin and members of the angulin family of
proteins (Furuse et al., 2014). Tricellulin is a member of the tight
junction-associated MARVEL protein family and is structurally
similar to occludin, with four transmembrane segments (Ikenouchi
et al., 2005). LSR/angulin-1 is the best characterized protein of the
angulin family and has an extracellular immunoglobulin-like
domain and one single-pass transmembrane domain (Masuda
et al., 2011; Higashi et al., 2013). Tricellulin is necessary for the
correct morphology of tricellular junctions and maintenance of
epithelial barrier properties (Ikenouchi et al., 2005; Nayak et al.,
2013). Lack of tricellulin in epithelial cells promotes abnormal
subcellular distribution of occludin and increased paracellular
permeability, suggesting that tricellulin contributes to maintaining
the integrity of epithelial bicellular junctions (Ikenouchi et al., 2005;
Krug et al., 2009). LSR/angulin-1 also regulates epithelial barrier
integrity and recruits tricellulin to tricellular junctions (Masuda
et al., 2011). The precise molecular architecture of tricellular
junctions is unknown, but epithelial tricellular junctions are
modeled with angulins at the core of the central sealing element,
associated with tricellulin, which engages claudins and thus
connects to bicellular junctions (Ikenouchi et al., 2008; Cording
et al., 2013; Masuda et al., 2011).
Recent studies have found tricellulin and LSR/angulin-1
transcripts specifically enriched in brain endothelial cells
(Daneman et al., 2010; Vanlandewijck et al., 2018). Localization
of tricellulin and LSR/angulin-1 protein in tricellular contacts of
BBB and blood–retinal barrier endothelium (Mariano et al., 2013;
Iwamoto et al., 2014; Sohet et al., 2015), but not in vascular beds
lacking barrier formation, such as the fenestrated vessels of the
choroid plexus and the circumventricular organs, or in the peripheral
vasculature (Iwamoto et al., 2014), has also been shown. Expression
and tricellular junctional localization of LSR/angulin-1 at the BBB
contributes to barrier maturation, as mice deficient for LSR/angulin-
1 show impaired barriergenesis, which may contribute to the
embryonic lethality of this mouse mutant (Mesli et al., 2004; Sohet
et al., 2015).
Fig. 4. CD4+ TEM cell diapedesis pathways across VE-cadherin–GFP
pMBMECs. Image series from time-lapse videos showing examples of
transcellular diapedesis (A) or paracellular diapedesis across bicellular
junctions (B) and tricellular junctions (C) over time. The top rows show VE-
cadherin–GFP at the endothelial junctions. The bottom rows show the same
field of view in phase-contrast images, highlighting CD4+ TEM cells interacting
with the pMBMECs. T cell diapedesis sites are indicated by arrows, allowing for
direct comparison of the absence or presence of a change in the VE-cadherin–
GFP pattern with the behavior of the T cells on the pMBMEC monolayer.
Junctional migration is visible as a gap in the junctional GFP signal. T cells are
highlighted with the dashed lines, where light blue lines show T cells localized
on top of the endothelium, whereas dark lines show a T cell below the
pMBMEC monolayer. The relative time of image acquisition in minutes is
indicated on the top left in each image. Image acquisition over the entire
pMBMEC monolayer was divided into eight tiles, which were subsequently
stitched together for analysis over the entire field of view. Lines visible in B and
C result from the stitching process used to join the individual image tiles.
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Fig. 5. Components of the tricellular junctions are downregulated upon inflammatory conditions. (A) Normalized values of read counts for tricellulin and
LSR/angulin-1 from anRNA sequencing analysis of non-stimulated pMBMECs, from five independent samples pooled from tenmice each. A threshold of 100 was
established for the normalized reads, above which all transcripts were considered as expressed. Data are presented as mean±s.d. (B) Gene expression of
tricellulin, LSR/angulin-1, angulin-2 and angulin-3 in non-stimulated pMBMECs was assessed by RT-qPCR. Relative quantification is represented by the ΔCT
value (average CT value of target gene−average CT value of β-actin). Data are presented as mean±s.d. of three experiments. (C) Immunoblot analysis and
quantification of the expression of tricellulin in non-stimulated (NS), IL-1βlo- or IL-1βhi-stimulated pMBMECs. EpH4 lysates and L cell lysates were used as positive
and negative controls, respectively. β-actin is shown as a loading control used for normalization during quantification. Bar graphs show the mean±s.d. of three
independent experiments. *P<0.05 (one-way ANOVA with a Tukey post hoc test). (D) Schematic representation of the isoforms of mouse LSR/angulin-1
and its domains. Numbers indicate the amino acid residues that comprise each domain. (E) Immunoblot analysis (top) and quantification (bottom) of the
expression of LSR/angulin-1 isoforms (isoform 1, 67 kDa; isoform 2, 64 kDa; and isoform 3, 58 kDa) in unstimulated, IL-1βlo- or IL-1βhi-stimulated pMBMECs.
EpH4 lysates and L cell lysates were used as positive and negative controls, respectively. β-actin is shown as a loading control used for normalization
during quantification. Bar graphs show the mean±s.d. of four independent experiments. *P<0.05; **P<0.01 (one-way ANOVA with a Tukey post hoc test).
AU, arbitrary units; n.d., not detected.
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Fig. 6. Targeting of LSR/angulin-1 by angubindin-1 in pMBMECs decreases paracellular CD4+ TEM cell diapedesis at bicellular junctions. (A) Schematic
representation of the structure of LSR/angulin-1 and the binding site of angubindin-1 in its N-terminal region. The image was adapted from Servier Medical
Art (http://smart.servier.com/), under the terms of a CC-BY 3.0 license. (B) Permeability of differently IL-1β-stimulated pMBMECmonolayers (NS, non-stimulated)
to 0.45 kDa Lucifer Yellow (left) and 3 kDa dextran (right), in the presence or absence of the control protein and angubindin-1, as indicated. Endothelial
permeability coefficient (Pe) values were calculated as previously described (Steiner et al., 2011). Bar graphs showmean±s.d. of three independent experiments,
with three replicates per condition. (C) Mean number of arrested CD4+ TEM cells in IL-1βlo- or IL-1βhi-stimulated endothelium, per field of view (FOV), while
targeting LSR/angulin-1with angubindin-1 as indicated. Bar graphs showmean±s.d. of three experiments. *P<0.05 (one-wayANOVAwith a Tukey post hoc test). (D)
Quantification of transcellular (red), bicellular junctional (blue) and tricellular junctional (gray) diapedesis events of CD4+ TEM cells across IL-1βlo- or IL-1βhi-stimulated
pMBMECs in the presence or absence of the control protein and angubindin-1, as indicated. Both IL-1β and protein stimulations were performed simultaneously for
16 h. In each condition, 100 diapedesis eventswere evaluated and normalized to the respective number of arrestedCD4+ TEM cells per FOV, fromat least four videos
from three independent experiments. Stacked bar graphs show mean±s.d. *P<0.05 (one-way ANOVA with a Tukey post hoc test). (E) Duration of CD4+ TEM cell
diapedesis through transcellular, bicellular junctional or tricellular junctional pathways, across IL-1βlo- or IL-1βhi-stimulated pMBMECs, in the presence or
absence of the control protein and angubindin-1, as indicated. Each data point represents an individual CD4+ TEM cell. The duration of the diapedesis of 100 cells was
evaluated per condition, from a total of three independent experiments. Individual data points are plotted, with mean and s.d. indicated.
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Fig. 7. See next page for legend.
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In this study, we confirmed expression of tricellulin and LSR/
angulin-1 in pMBMECs at the mRNA and protein levels; however,
precise subcellular localization of tricellulin and LSR/angulin-1
using available polyclonal and monoclonal antibodies failed. High
but not low inflammatory conditions induced downregulation of
both tricellulin and LSR/angulin-1 (specifically isoform 2) in
pMBMECs. Isoform 2 is the most highly expressed LSR/angulin-1
isoform in pMBMECs; however, the functional relevance of
differential expression of the LSR/angulin-1 isoforms in
establishing tricellular junctions and barrier integrity are not yet
known. In accordance with observations in mouse models of stroke
and MS (Sohet et al., 2015), we found that decreased expression of
tricellulin and LSR/angulin-1 in IL-1βhi-stimulated pMBMECs was
accompanied with a trend for increased permeability of pMBMEC
monolayers to small molecules. Taken together, these observations
suggest that both tricellulin and LSR/angulin-1, and thus tricellular
junctions, play a key role in overall junctional barrier maturation of
the BBB. Exactly how tricellulin and LSR/angulin-1 regulate the
unique barrier stability at tricellular, and potentially bicellular, brain
endothelial junctions remains to be shown, and this would require
development of tools allowing the subcellular localization of
tricellulin and LSR/angulin-1 to be defined.
Although we describe here, for the first time, CD4+ TEM cell
diapedesis across tricellular junctions of the BBB, immune cell
extravasation through tricellular endothelial contacts in peripheral
vascular beds has been observed previously. Neutrophils and
monocytes have been shown to preferentially cross the tricellular
contacts of cytokine-stimulated human umbilical vein endothelial
cells (HUVECs) in vitro (Burns et al., 1997; Winger et al., 2014).
Additionally, intravital and confocal microscopy has demonstrated
that leukocytes cross endothelial tricellular contacts in the inflamed
mouse cremaster muscle (Wang et al., 2006; Sumagin and Sarelius,
2010). Lack of expression of tricellulin and LSR/angulin-1 in
peripheral vascular endothelial cells (Iwamoto et al., 2014) suggests,
however, that these tricellular contacts do not form tight tricellular
junctions. In fact, in contrast to the BBB, where we observed
preferential CD4+ TEM cell diapedesis via tricellular junctions under
low inflammatory conditions, the diapedesis of leukocytes through
tricellular endothelial contacts was observed under inflammatory
conditions. Thus, we propose that CD4+ TEM cell diapedesis across
tricellular junctions of the BBB vasculature is a unique process
allowing tight control of T cell entry into the CNS. Additional studies
on the precisemolecular structure and composition of BBB tricellular
junctions will be vital to clarify the molecular underpinnings of CD4+
TEM cell diapedesis across the BBB at these junctional sites.
In peripheral vascular beds, inflammation and increased
permeability correlate with increased leukocyte extravasation via
the paracellular pathway. In contrast, impaired barrier properties of
the BBB correlate with increased transcellular CD4+ TEM cell
diapedesis (Abadier et al., 2015; Lutz et al., 2017; Wimmer et al.,
2019). We have previously demonstrated that in IL-1βlo-stimulated
pMBMECs, where junctional integrity is preserved, diapedesis of
CD4+ TEM cells occurs preferentially via the paracellular route.
However, when junctional barrier properties are compromised, such
as in IL-1βhi-stimulated pMBMECs, the number of CD4+ TEM cells
that migrate transcellularly increases significantly (Abadier et al.,
2015). Similarly, absence of PECAM-1 in pMBMECs leads to an
impairment of BBB junctional integrity, and although PECAM-1 is
not required for CD4+ TEM cell diapedesis across the BBB, its
absence directs CD4+ TEM cell diapedesis to the transcellular
pathway (Wimmer et al., 2019). Altogether, it seems that
modifications or loss of BBB junctional molecules results in a
shift to enhanced transcellular T cell diapedesis.
Given that we observed downregulation of tricellulin and LSR/
angulin-1 in IL-1βhi-stimulated pMBMECs, we wondered whether
protein-based targeting of tricellular junctional molecules would also
decrease paracellular diapedesis in favor of transcellular T cell
diapedesis. Because mice that lack LSR/angulin-1 are embryonically
lethal (Mesli et al., 2004), we used angubindin-1 as an LSR/angulin-1
blocking protein. Angubindin-1 has previously been shown to bind to
LSR/angulin-1 in epithelia and in BBB endothelium, both in vitro
and in vivo, and to remove LSR/angulin-1 from tricellular junctions
(Krug et al., 2017; Zeniya et al., 2018). In our study, we observed that
incubating IL-1βlo-stimulated pMBMECswith angubindin-1 reduced
paracellular T cell diapedesis across bicellular junctions and caused a
trend towards increased transcellular diapedesis, while T cell
diapedesis across tricellular junctions was surprisingly not affected.
Pre-treatment of IL-1βhi-stimulated pMBMECs with angubindin-1
did not affect the cellular pathway of T cell diapedesis. This
underscores that a shift in the cellular pathway of T cell diapedesis
across pMBMECs induced by angubindin-1 can only be observed
under IL-1βlo conditions when the junctional architecture is still
intact. Of note, angubindin-1 did not induce visible changes in
expression and localization of junctional or adhesion molecules and
did not affect pMBMEC permeability.
In cultured epithelial cells and a rat in vitro model of the BBB,
angubindin-1 has been found to engage the extracellular domain of
Fig. 7. Protein targeting of claudin-5 in pMBMECs decreases paracellular
CD4+ TEM cell diapedesis at bicellular junctions. (A) Schematic model of
claudin-5 modulator (cCPE variant) binding to claudin-5 that sterically blocks
claudin polymerization. cCPE (gray surface) was mutated at three positions
(N218Q, Y306W and S313H; red) to enable binding to claudin-5 [backbone
shown as ribbons; transmembrane helices, violet; extracellular segment (ECS)
1, blue; ECS2, green]. N218Q (red, left) facilitates interaction with ECS1,
Y306W (red, right) and S313H (red, middle) facilitate interaction with ECS2.
Mutation L315A (pink) together with Y306A blocks cCPE interaction with
claudins. ECS2 positions critical for interaction are shown as green spheres.
Phospholipids of the membrane are shown as lines (head groups in color).
Image created using cCPE–claudin-4 crystal structure (PBD ID: 5b2g) and
data from Neuhaus et al. (2018), generated with Maestro and Pymol
(Schrödinger). (B) Permeability of differently stimulated pMBMEC monolayers
(NS, non-stimulated) to 0.45 kDa Lucifer Yellow (left) and 3 kDa dextran (right),
in the presence or absence of claudin (Cldn) modulator or control cCPE
proteins, as indicated. Endothelial permeability coefficient (Pe) values were
calculated as previously described (Steiner et al., 2011). Bar graphs show
mean±s.d. of four independent experiments, with three replicates per
condition. (C) Immunofluorescence staining of claudin-5 (red) in pMBMEC
monolayers. Comparable staining was obtained for claudin-5 in either non-
stimulated (NS), IL-1βlo- or IL-1βhi-stimulated pMBMECs, in the presence or
absence of the cCPE proteins. Nuclei were stained with DAPI (blue). Three
independent experiments were performed. Scale bars: 50 µm. (D) Mean
number of arrested CD4+ TEM cells in IL-1βlo- or IL-1βhi-stimulated
endothelium, per field of view (FOV), while targeting claudin-5, as indicated.
Data are presented as mean±s.d. of three experiments. (E) Quantification of
transcellular (red), bicellular (blue) and tricellular (gray) diapedesis events of
CD4+ TEM cells across IL-1βlo- or IL-1βhi-stimulated pMBMECs, in the presence
or absence of the cCPE peptides. Both IL-1β and claudin modulator
stimulations were performed simultaneously for 16 h. In each condition, 100
diapedesis events were evaluated and normalized to the respective number of
arrested CD4+ TEM cells per FOV, from at least four videos from four
independent experiments. Stacked bar graphs showmean±s.d. *P<0.05 (one-
way ANOVA with a Tukey post hoc test). (F) Duration of CD4+ TEM cell
diapedesis through transcellular, bicellular junctional or tricellular junctional
pathways, across IL-1βlo- or IL-1βhi-stimulated pMBMECs, in the presence or
absence of the cCPE proteins. Each data point represents an individual CD4+
TEM cell. The duration of the diapedesis of 100 cells was evaluated per
condition, from a total of four independent experiments. Individual data
points are plotted, with mean and s.d. indicated.
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LSR/angulin-1 and induce a transient relocation of LSR/angulin-1
and tricellulin from the tricellular to bicellular junctions (Krug et al.,
2017). This is accompanied by a transient opening of the tricellular
junctional complexes and a decrease in transepithelial and
transendothelial resistance, which mimics the situation under
exacerbated inflammation (Krug et al., 2017; Zeniya et al., 2018).
In vivo application of angubinin-1 induces loss of immunodetection
of LSR/angulin-1 in BBB tricellular junctions and increased BBB
permeability (Zeniya et al., 2018; Krug et al., 2017).
Lack of suitable reagents prevented us from obtaining formal
evidence for the localization of LSR/angulin-1 and tricellulin to
tricellular junctions in pMBMEC monolayers, and thus potential
angubindin-1-induced redistribution of these tricellular junctional
proteins, in the present study. Fluorescently labeled angubindin-1
was observed to be rapidly taken up by pMBMECs (data not
shown), suggesting internalization of LSR/angulin-1 by pMBMECs
potentially also occurs outside of tricellular junctions. Because
angubindin-1 can also bind to angulin-3 and partly remove LSR/
Fig. 8. Abluminal chemokines increase CD4+ Th1 cell diapedesis via tricellular junctions of pMBMECs. (A) Cumulative analysis of transcellular (red),
bicellular (teal) and tricellular (gray) diapedesis events of CD4+ Th1 cells across IL-1βlo- or IL-1βhi-stimulated pMBMECs, as shown in Figs 6D and 7E (conditions
no protein). In each condition, 100 diapedesis events were evaluated and normalized to the respective number of arrested CD4+ Th1 cells per field of view
(FOV), from at least four videos from four independent experiments. Stacked bar graphs showmean±s.d. **P<0.01 (one-way ANOVAwith a Tukey post hoc test).
(B) Schematic representation of in vitro live imaging of T cell extravasation across primary mouse brain microvascular endothelial cells (pMBMECs) cultured on
nanoporous silicon nitride (NPN)membranes (µSiM-CVB) under physiological flow conditions (from right to left; arrows) with recombinant mouseCCL2 andCCL5
(both 100 ng/ml) in the bottom compartment. (C) Mean number of arrested Th1 cells on IL-1βhi-stimulated pMBMECs under physiological flow conditions in
the µSiM-CVB assay, in the presence (with) or absence (w/o) of CCL2 and CCL5 in the bottom channel. (D) Mean percentage of transmigrated Th1 cells across
IL-1βhi-stimulated pMBMECs in the µSiM-CVB assay, in the presence or absence of CCL2 and CCL5. Each data point shown in C,D represents the mean of the
two FOVs per movie. (E) Quantification of transcellular (red), bicellular (teal) and tricellular (gray) diapedesis events of Th1 cells across IL-1βhi-stimulated
pMBMECs in the µSiM-CVB assay. Events with an unclear transmigration path are shown in yellow. Data in C–E are mean±s.d. of three experiments, with at least
duplicates for each condition. *P<0.05; **P<0.01; n.s., not significant (two-tailed, unpaired t-test).
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angulin-1 and tricellulin from epithelial tricellular junctions (Krug
et al., 2017), we cannot exclude that the effect on CD4+ TEM cell
diapedesis across pMBMECs might arise not only from the
modulation of LSR/angulin-1, but also from a general effect in
the function or location of tricellulin, LSR/angulin-1 and angulin-3.
Thus, whether angubindin-1 disturbs tricellular and bicellular
junctional compositions of pMBMECs and how its presence
reduces paracellular T cell diapedesis across IL-1βlo-stimulated
pMBMECs remains to be shown.
Targeting claudin-5 as a major component of the bicellular
junctions also influenced the CD4+ TEM cell diapedesis pathway.
Similar to the effects observed upon angubindin-1 treatment,
incubation of IL-1βlo-stimulated pMBMECs with a Cldn5
modulator decreased paracellular diapedesis through bicellular
junctions, leading to increased transcellular diapedesis, with no
effects seen in diapedesis through tricellular junctions. No
noticeable effects on CD4+ TEM cell diapedesis and barrier
integrity were detected upon incubation of IL-1βhi-stimulated
pMBMECs with the Cldn5 modulator. In agreement with a
previous study by Neuhaus and colleagues (Neuhaus et al., 2018),
no significant differences were seen in claudin-5, ZO-1, ICAM-1,
VCAM-1 and VE-cadherin expression and localization. In contrast
to the findings of this previous study, we did not observe an increase
in permeability across pMBMEC monolayers upon incubation with
the Cldn5 modulator (Neuhaus et al., 2018). This apparent
difference may be due to differences in claudin-5 expression
levels, tight junction assembly or architecture between the different
in vitro BBB models used, affecting accessibility or modulation of
claudin-5 by the Cldn5modulators. In addition, in our flow chamber
the Cldn5 modulator incubation was only possible from the luminal
side of the pMBMEC monolayer, whereas the previous study added
the cCPE proteins from the luminal and abluminal sides, which may
explain the different observations (Neuhaus et al., 2018). The Cldn5
modulator most likely engages non-polymerized claudin-5 and thus
sterically prevents incorporation of claudin-5 into polymeric tight
junction strands. This may be achieved more efficiently if cCPE is
also applied from the abluminal side (Eichner et al., 2017; Neuhaus
et al., 2018). Fluorescently tagged Cldn5modulator was observed to
be internalized by pMBMECs (data not shown), suggesting that the
Cldn5 modulator might interfere with junctional dynamics and/or
remodeling required to establish the necessary scaffolds allowing
for paracellular T cell diapedesis (Yamazaki et al., 2011).
Alternatively, the Cldn5 modulator may affect the formation of
endothelial-derived extracellular vesicles containing claudin-5
(Paul et al., 2016), thus shifting the cellular pathway of T cell
diapedesis to transcellular sites.
Alterations of the molecular architecture and/or dynamics of
BBB bicellular and tricellular BBB junctions may furthermore
promote a modification in the junctional scaffold, favoring
transcellular over paracellular T cell diapedesis across the BBB. A
possible contribution of the endothelial cytoskeleton is likely,
because tight junctions and adherens junction proteins are tightly
connected to the cytoskeleton (Bauer et al., 2014). Claudin-5 is
bound to the endothelial cytoskeleton through the interaction with
ZO-1 and ZO-2 (also known as TJP2) (Itoh et al., 1999). Also, data
from epithelial cell studies has revealed that tricellulin is involved in
the regulation of F-actin organization through Tuba (also known as
DNMBP), a guanine-nucleotide-exchange factor that activates
Cdc42 (Oda et al., 2014). Despite the fact that the organization
and composition of tricellular tight junctions of the BBB are just
starting to be unveiled, we can speculate that these tricellular
junctions are connected to the BBB actin cytoskeleton. Therefore,
we cannot exclude the hypothesis that bicellular and tricellular
junctional disarrangement in the BBB endothelium promotes
cytoskeleton reorganization and thus accommodates more CD4+
TEM cell transcellular migration events, through mechanisms yet to
be clarified. On the other hand, chemotactic signaling could also be
affected by altered junctions, as both transcellular and paracellular
T cell diapedesis across pMBMECs depend on G-protein-coupled
recetor signaling (Abadier et al., 2015; Rudolph et al., 2016). Our
present study indeed suggests a specific role for BBB tricellular
junctions in conveying chemotactic cues from the abluminal to the
luminal side of the BBB, because presence of abluminal chemokines
shifted T cell diapedesis across pMBMECmonolayers specifically to
tricellular junctions.
In conclusion, by identifying BBB tricellular junctions as key
structures controlling T cell diapedesis across the BBB, our study
further underscores that the BBB plays an active role in controlling
T cell entry into the CNS by mechanisms that are distinct from those
that apply in peripheral vascular beds. Understanding the precise
molecular architecture of theBBB junctional complexes and how their
alteration is connected to the shift from paracellular to transcellular
T cell diapedesis will allow us to improve our understanding of the
role of the BBB in maintaining CNS homeostasis and immunity.
MATERIALS AND METHODS
Mice and mouse housing
Wild-type C57BL/6J mice were obtained from Janvier (Genest Saint Isle,
France). VE-cadherin–GFP knockin C57BL/6J mice were kindly provided
by Dietmar Vestweber (Max Planck Institute for Molecular Biomedicine,
Muenster, Germany; Winderlich et al., 2009). Mice were housed in
individually ventilated cages under specific pathogen-free conditions at
22°C and 55% relative humidity, with free access to chow and water. Animal
procedures executed were approved by the Veterinary Office of the Canton
Bern (permit no. BE42/14 and BE31/17) and are in linewith institutional and
standard protocols for the care and use of laboratory animals in Switzerland.
In vitro BBB model and cell lines
Isolation and culture of primary mouse brain microvascular endothelial cells
(pMBMECs) from 7–12-week-old wild-type or VE-cadherin–GFP knockin
C57BL/6J mice were performed exactly as previously described (Coisne
et al., 2005; Steiner et al., 2011). The unique tightness of this endothelial
barrier is essential for studying the cellular migration pathway of T cells
across the BBB under physiological flow, as brain endothelial cell lines not
mimicking tight barrier properties do not allow delineation of different
cellular pathways of T cell diapedesis across the BBB under flow in vitro
(Steiner et al., 2010). Limitations apply to this in vitro BBB model, because
knockdown or silencing approaches are not possible when using primary
mouse brain microvascular endothelial cells that are grown to confluence
over 6–7 days before being used for experiments. EpH4 cells and L cells,
established and cultured as previously described (Reichmann et al., 1992;
Fialka et al., 1996; Furuse et al., 1999), were grown to confluency on
Matrigel-coated surfaces (Corning, NY, USA) before western blotting or
immunofluorescence staining.
T cells
For the in vitro live-cell imaging experiments on pMBMECmonolayers, we
used the encephalitogenic CD4+ TEM effector-memory proteolipid protein
(PLP) peptide amino acids 139–153-specific T-cell line SJL.PLP7 (CD4+
TEM cells; Engelhardt et al., 1998), as described previously (Abadier et al.,
2015; Steiner et al., 2010), or in vitro polarized encephalitogenic T helper 1
cells (Th1 cells) from T cell receptor transgenic 2D2 mice (2D2 TCRMOG
mice) as previously described (Haghayegh Jahromi et al., 2019).
In vitro live-cell imaging
In vitro live-cell imaging of CD4+ TEM interacting with VE-cadherin–GFP
knockin pMBMECs cultured in a Matrigel-coated (Corning, NY, USA)
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μ-Dish (35 mm, low; ibidi, Martinsried, Germany) was perfomed exactly as
previously described (Abadier et al., 2015). Briefly, 106 CD4+ TEM cells/ml
were perfused over a monolayer of pMBMECs in a custom-made flow
chamber for the first 5 min at 0.1 dyn/cm2 (0.01 Pa) followed by 25 min of
physiological shear at 1.5 dyn/cm2 (0.15 Pa). For high-resolution image
acquisition over the entire pMBMEC monolayer, eight adjacent fields of
view, referred to as tiles, were imaged individually with the 40×
magnification objective of an inverted microscope (AxioObserver, Zeiss,
Oberkochen, Germany). For evaluation purposes, tiles were combined via
stitching to a larger overview using the ZEN software (blue edition, Zeiss,
Oberkochen, Germany), and the number of arrested CD4+ TEM cells on
pMBMECs was counted 30 s after applying physiological flow. Diapedesis
events were visualized by combining phase contrast, to properly identify
T cells, with the GFP fluorescence channel, to visualize the junctions. Then,
the diapedesis events were divided into three categories: transcellular, where
the junctions (i.e. the GFP signal) remained intact upon diapedesis;
paracellular across bicellular junctions, when the GFP signal was transiently
lost at the junctions between two adjacent endothelial cells; and paracellular
across tricellular junctions, when the GFP signal was transiently lost at the
junctions where three endothelial cells met (exemplified in Fig. 4). Distance
of T cell crawling and diapedesis duration was manually tracked for each
individual T cell using FIJI software (NIH, Bethesda, MD, USA).
In vitro live-cell imaging of Th1 cell interaction on pMBMEC
monolayers grown on nanoporous silicon nitride (NPN) membranes in the
two-chamber µSiM-CVBmicrofluidic devices was performed as previously
described (Mossu et al., 2019). Th1 cells were resuspended in migration
assay medium (DMEM, 5% FBS, 4 mM L-glutamine and 25 mM HEPES)
at 106 cells/ml. Recombinant mouse MCP-1/CCL2 (Biolegend) and
recombinant mouse RANTES/CCL5 (Biolegend) were each added at
100 ng/ml to the bottom compartment 2 h prior in vitro live-cell imaging.
Accumulation of Th1 cells on VE-cadherin–GFP pMBMECs in the µSiM-
CVBmicrofluidic devicewas allowed for 4 min at a low shear (0.1 dyn/cm2,
0.01 Pa), followed by physiological shear (1.5 dyn/cm2, 0.15 Pa) for an
additional 30 min. For image acquisition, two adjacent fields of view were
collected at with a 10× objective with an inverted microscope
(AxioObserver, Zeiss, Feldbach, Switzerland) with phase contrast and
fluorescence illumination using a monochrome charge-coupled device
camera (AxioCam MRm Rev, Carl Zeiss). Image analysis was performed
exactly as outlined above. A fourth category, unclear path, had to be added
when analysing diapedesis events that could not be assigned to one of the
three categories in the µSiM-CVB.
Image segmentation
To determine whether the cellular pathways of T cell diapedesis across
pMBMECmonolayers are random or not random, we established a baseline
model corresponding to a situation where the T cells would randomly
choose a location for transmigration. In such a null model, the probability of
attaching to a specific location on the cell monolayer is directly proportional
to the frequency of its occurrence, and therefore, based on a 2D microcopy
image of the VE-cadherin–GFP pMBMEC monolayer, we measured these
frequencies by counting the number of pixels belonging to each category.
Boundary segmentation of endothelial junctions was perfomed using the
PlantSeg algorithm (Wolny et al., 2020) originally developed for
plant cell segmentation, which was found perfectly suitable for application
on VE-cadherin–GFP+ pMBMEC monolayers. We used the
‘confocal_2D_unet_bce_dice_ds1x’ model (with GASP partitioning) for
segmentation of VE-cadherin–GFP+ pMBMEC monolayers and validated
the result by visual inspection. The input image used was a mean-intensity
projection of the complete z-stack, from a collection of eight adjacent fields of
view, as described above in the section ‘In vitro live-cell imaging’. This image
was background corrected using the Fiji (Schindelin et al., 2012) method
‘Subtract Background’with a radius of 20 pixels. The segmentation output was
a binary image of the cell boundaries that was subsequently skeletonized and
processed with skan (https://github.com/jni/skan) to identify bicellular and
tricellular junctions, which were then turned into binary images as well. As
bicellular and tricellular junctions are geometric lines and points without a
thickness, we assigned a specific radius to them by dilating the obtained
binary images. This allowed us to estimate the abundance of each category –
cell surface, bicellular and tricellular junction – by counting the number of
pixels belonging to each category. Overlapping regions were assigned first to
tricellular junctions, then bicellular junctions and finally to the cell surface.
Chemotaxis assays
In vitro polarized Th1 cells were labeled with 1 μM CellTracker Green
(CMFDA Dye, Life Technologies) at 37°C with 5% CO2 for 30 min.
Chemotactic behavior was assessed as previously described (Nishihara et al.,
2020) by allowing 105 Th1 cells to migrate for 2 h across laminin (from
Engelbreth–Holm–Swarm murine sarcoma basement membrane, Sigma)
coated Millicell filters (pore size 5.0 μm, pore density 2.0×106 pores/cm2,
growth area 0.33 cm2;Millicell,MCMP24H48)with 0, 1, 10, 100 or 1000 ng/
ml recombinant mouse CCL2 (Biolegend) or recombinant mouse CCL5
(Biolegend) in migration assay medium (DMEM, 5% FBS, 4 mM L-
glutamine and 25 mM HEPES) in the bottom compartment. Migrated Th1
cells were collected and counted with an Attune NxT Flow Cytometer
(Thermo Fisher Scientific) by gating on CMFDA-positive live cells.
Serial block-face scanning electron microscopy
CD4+ TEM cells were allowed to interact with pMBMECs under
physiological flow conditions (1.5 dyn/cm2, 0.15 Pa) for 13 min, a
timepoint at which most of the T cells were undergoing diapedesis.
Afterwards, the assay was fixed by perfusion of 2.5% glutaraldehyde, 2 mM
CaCl and 0.15 M cacodylate (pH 7.4) through the flow chamber. Samples
were rinsed three times for 5 min in ice-cold 0.15 M Na cacodylate and then
incubated in 0.15 M Na cacodylate solution containing 2% OsO4 and 1.5%
potassium ferrocyanide for 1 h at room temperature. After a washing step
with water, samples were incubated in 0.64 M pyrogallol for 20 min at room
temperature, then were washed again. The samples were incubated in 2%
OsO4 for 30 min at room temperature, and after another washing step,
incubated overnight in a solution of 0.15 M gadolinium acetate (LFG
Distribution, Lyon, France) and 0.15 M samarium acetate (LFG
Distribution, Lyon, France). The next day, samples were washed and
incubated in Walton’s lead aspartate (Walton, 1979) at 60°C for 30 min,
then rinsed with water. After staining, the samples were dehydrated in a
graded ethanol series (20%, 50%, 70%, 90%, 100%, 100%) at 4°C, each
step lasting 5 min. They were then embedded with Durcupan resin mixed
with ethanol at ratios of 1:3 (v/v), 1:1 and 3:1, each step lasting 2 h. Samples
were then infiltrated with pure Durcupan overnight. The samples were
transferred to fresh Durcupan, and the resin was polymerized for 3 days at
60°C. Sample blocks were mounted on aluminum pins (Gatan, Pleasonton,
CA, USA) with a conductive epoxy glue (CW2400, Circuitworks,
Kennesaw, GA, USA). Care was taken to have osmicated material directly
exposed at the block surface in contact with the glue in order to reduce
specimen charging under the electron beam. Pyramids with a surface of
∼500×500 μm2 were trimmed with a razor blade and imaged with an FEI
Quanta 250 FEG with Gatan 3View2XP. A total of 2000 images were
acquired per sample, with a slice thickness of 60 nm and a pixel size of
0.012 μm. For the visualization of the images and full analysis of the dataset,
we used 3dmod software (University of Colorado, Boulder, CO, USA) and
FIJI (NIH, Bethesda, MD, USA). Manual segmentation was performed
using FIJI (NIH, Bethesda, MD, USA) and UCSF Chimera (University of
California, San Francisco, CA, USA).
Analysis of T cell protrusions
For the analysis of the images taken by SBF-SEM, we used the program
3dmod (University of Colorado Boulder, Colorado, USA). For each
condition (IL-1βlow- or IL-1βhigh-stimulated pMBMECs), ten T cells that
were in the stage of probing were randomly chosen to be analyzed. We
defined protrusions as T cell processes interfering with the endothelium. We
determined the range from the smallest protrusion observed, having a
diameter (in the x-axis) of roughly 90 nm and a depth (in the y-axis) of
roughly 40 nm, to the biggest protrusion observed, having a diameter (in the
x-axis) of roughly 1700 nm and a depth (in the y-axis) of roughly 800 nm.
In vitro immunofluorescence staining
Confluent pMBMEC monolayers were stained precisely as previously
described (Lazarevic and Engelhardt, 2016). Briefly, pMBMECs were
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gently washed with Dulbecco’s phosphate buffered saline (DPBS) and
subsequently fixed with either 1% paraformaldehyde (PFA; MERCK,
Darmstadt, Germany) in DPBS at room temperature for 10 min or with
−20°C methanol (for claudin and occludin staining), for 1 min. Unspecific
binding was blocked by incubating the cells with Tris-buffered saline (TBS)
containing 5% skim milk and 0.2% Triton X-100 (BioRad Laboratories,
Hercules, CA, USA). Primary and secondary antibodies were incubated for
1 h at room temperature, and the staining was analyzed using a Nikon
Eclipse E600 microscope connected to a Nikon Digital Camera
DXM1200F, with the Nikon NIS-Elements BR3.10 software (Nikon,
Egg, Switzerland). Images were processed and mounted using Adobe
Illustrator software.
In vitro permeability assays
In vitro permeability of the pMBMEC monolayers was assessed by
measuring the clearance of Alexa Fluor 680-labeled 3 kDa dextran (Thermo
Fisher Scientific, Carlsbad, CA, USA) and of 0.45 kDa Lucifer Yellow
(Sigma-Aldrich Chemie GmbH, Buchs, Switzerland), exactly as described
previously (Cecchelli et al., 2014, 1999; Coisne et al., 2005; Steiner et al.,
2010). In brief, the fluorescent tracers diffusing across the pMBMEC
monolayers were collected from the bottom well every 20 min for a total of
60 min. Fluorescence intensity for Alexa Fluor 680-labeled 3 kDa dextran
and Lucifer Yellow was measured by infrared imaging (Odyssey
Quantitative Fluorescence Imaging System, LI-COR, Bad Homburg,
Germany) and with a Tecan Infinite M1000 multi-well reader (Tecan
Trading AG), respectively. The endothelial permeability coefficient (Pe)
was calculated using the clearance principle to obtain a concentration-
independent transport parameter, as previously described in detail (Coisne
et al., 2005). The experiments were performed in triplicates for each
condition.
RT-qPCR analysis
RNA extraction from pMBMEC culture was done using the High Pure RNA
Isolation Kit (Hoffman-La Roche, Basel, Switzerland). Afterwards, cDNA
was obtained from the total RNA of each sample with the SuperScript III
First-Strand Synthesis System (Invitrogen, Carlsbad, CA, USA), and
RT-qPCR was done as previously described (Lyck et al., 2009). Selected
sets of genes to be analyzed were tested using Takyon Low Rox SYBR
MasterMix dTTP Blue (Eurogentec, Lieg̀e, Belgium). The sequences of the
primers used were as follows: for tricellulin, 5′-CTGGCCTGACCGAGA-
CAA-3′ and 5′-CAACGACGGGTCATTTATCC-3′; for LSR/angulin-1, 5′-
GCTGTGACCCTGGGAGACTA-3′ and 5′-CGAAGGTCAGGTCAGC-
ATTT-3′; for angulin-2, 5′-AATGTGGAGAGGCGCTTG-3′ and 5′-TG-
TATGATCCAAGAAGCAGTATGG-3′; and for angulin-3, 5′-CAG-
TTGCTGCTGCTATGTCC-3′ and 5′-TGCTTTCCCTGCTTCATACA-3′.
β-actin was used as the endogenous control, with the primer sequences of 5′-
AAGGCCAACCGTGAAAAGAT-3′ and 5′-GTGGTACGACCAGAGG-
CATAC-3′. All RT-qPCR reactions were done in triplicates for each sample
and performed using the Viia7 Real-Time PCR System (Thermo Fisher
Scientific, Waltham, MA, USA). ΔCT value was obtained (average CT
value of target gene−average CT value of β-actin).
Antibodies and cytokines
The primary and secondary antibodies used in this study are described in
Table S1. IL-1β (PeproTech, Rocky Hill, NJ, USA) stimulation of
pMBMEC monolayers was done for 16–20 h at a concentration of
0.05 ng/ml (IL-1 βlo) or 20 ng/ml (IL-1 βhi). Angubindin-1, used to detect
LSR/angulin-1, was coupled with DyLight 550 NHS ester with the DyLight
Antibody labeling kit (Thermo Fisher Scientific, Carlsbad, CA, USA),
according to the manufacturer’s instructions.
SDS–PAGE
pMBMECs fromwild-type C57BL/6J mice, EpH4 and L-cells were lysed in
RIPA buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA solution, 1% Triton
X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl and 1 mM
PMSF], in the presence of protease inhibitor cOmplete ULTRA Tablets,
Mini, EDTA-free, EASYpack (1 tablet/10 ml buffer; Roche Diagnostics,
Mannheim, Germany). Protein concentration was measured using the Pierce
BCA Protein Assay Kit (Thermo Scientific Pierce Protein Biology,
Waltham, USA), according to the manufacturer’s instructions. A total of
5–20 μg of each sample was loaded onto a 10% SDS-polyacrylamide gel
and transferred to a nitrocellulose membrane (Amersham Protan, GE
Healthcare, United Kingdom) using a Trans-Blot Turbo transfer system
(BioRad Laboratories, Hercules, CA, USA), according to the
manufacturer’s instructions. Membranes were blocked with Rockland
Buffer (Rockland, Limerick, PA, USA) for 1 h at room temperature and
incubated overnight at 4°C with the primary antibodies (Table S1). On the
following day, membranes were washed and incubated with secondary
antibodies (Table S1), for 1 h at room temperature. Proteins were detected
using an Odyssey near infrared imaging system and software (LI-COR
Biotechnology, Lincoln, NE, USA). Band intensity was quantified using
FIJI software (NIH, Bethesda, MD, USA) and normalized against β-actin
intensity.
Blocking proteins and blocking assays
To target claudin-5 as a component of endothelial bicellular junctions, the
following recombinant proteins were used: GST–cCPE_Y306W/S313H
(referred to in this study as ‘claudin-1, -3, -4, -5 modulator’) and GST–
cCPE_N218Q/Y306W/S313H (referred to in this study as ‘claudin-5
modulator’). GST–cCPE_Y306/L315A (referred to in this study as ‘control
protein’) was used as a negative control. The proteins were produced as
described previously (Neuhaus et al., 2018; Protze et al., 2015). The
pMBMEC monolayers were incubated with these modulators at a
concentration of 10 µg/ml for 16 h, and the modulators were removed with
a washing step immediately before performing the immunofluorescence
staining, in vitro permeability assays or in vitro live-cell imaging experiments.
To target LSR/angulin-1 at the tricellular junctions, angubindin-1 (Ib421-
664) was used. C2II592-721 (referred to in this study as ‘control protein’)
was used as a negative control. Both proteins were produced as previously
described (Krug et al., 2017; Nagahama et al., 2004; Blocker et al., 2000).
Both proteins were incubated with the pMBMEC monolayer at a
concentration of 5 µg/ml for 16 h and removed with a washing step
immediately before performing the immunofluorescence staining, in vitro
permeability assays or in vitro live-cell imaging experiments.
Statistics
Statistical analysis was performed using GraphPad Prism 6.0 software (San
Diego, CA, USA). To compare two groups, an unpaired t-test with Welch’s
correction was performed and for the comparison of three groups, we
performed a one-way ANOVA with post hoc Tukey test. A P-value <0.05
was used as the level of significance.
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